“Hands and legs began to be taken away”: Anatoly Chubais ended up in intensive care in Europe with Guillain-Barré syndrome


    "Hands and legs began to take away": Anatoly Chubais ended up in intensive care in Europe with Guillain — Barre syndrome

    Anatoly Chubais

    Last night, Ksenia Sobchak, in her telegram channel “Bloody Lady”, announced that Anatoly Chubais was in intensive care.

    I just spoke to Avdotya [Smirnova]. The state is unstable. It became bad, arms and legs suddenly began to take away. Here is Anatoly Borisovich's personal comment: “I was hospitalized in one of the European clinics with a diagnosis of Guillain's syndrome — Barre”. Condition of moderate severity, stable”,

    — wrote Sobchak.

    Guillain Syndrome — Barre — it is a rare condition in which a person's immune system attacks their own peripheral nerves. In severe cases, this can lead to complete paralysis, but according to the WHO, most people recover. Last year, the European Medicines Agency (EMA) reported that Guillain's syndrome — Barre will be included in Janssen's list of rare side effects of the coronavirus vaccine. Symptoms were also observed in rare cases after vaccination with AstraZeneca.

    The following information also appeared in the news channel “Caution, the news” run by the Sobchak team:

    The room where Chubais was, when he felt unwell, specialists in chemical protection suits examined him.

    Later information that Chubais was hospitalized in Europe with Guillain's syndrome — Barre, confirmed TASS through an anonymous source. According to the interlocutor of the agency, Chubais's condition has already improved.

    Shortly after the start of the special operation in Ukraine, Anatoly Chubais left the post of special presidential envoy for sustainable development and left Russia. He did not make any official statements about his position, but Bloomberg sources reported that Chubais resigned due to disagreement with the actions of Vladimir Putin.

    The blogger Vacilek was the first to share the news.


    Please enter your comment!
    Please enter your name here